Delivery Order SPE2DB20D2104-SPE2DB25FMXAH
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injectors (two-pack units) valued at $1,253.93. Awarded on August 28, 2025, with an ultimate completion date of August 29, 2025, this firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of...
- The Defense Logistics Agency awarded a $2,273.25 delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector (2-pack) on July 18, 2025, with completion scheduled for July 21, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is located in...
- The Defense Logistics Agency awarded a $5,569.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.15 mg auto-injectors (2-pack units) on August 8, 2025, with an ultimate completion date of August 11, 2025. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place...
- The Defense Logistics Agency awarded a $16,063.67 delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.15 mg auto-injectors (2-pack units) on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The place of performance is listed as Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (2-pack units) valued at $1,733.94. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 25, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract contains no set-aside designation, reflecting the company's capability to compete openly for...
- The Defense Logistics Agency awarded a $1,499.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (2-pack units). This is a non-set-aside competitive award with an ultimate completion date of July 28, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract is to be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $2,048.11 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (two-pack units). This firm fixed-price delivery order, with an ultimate completion date of July 31, 2025, represents a competitively awarded contract with no set-aside designation. The supplies will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,194.57 to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (2-pack units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 12, 2025, and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The award was issued to AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,763.22 firm fixed-price delivery order to AmerisourceBergen Drug Corp for epinephrine 0.15 mg auto-injectors (two-pack) on August 15, 2025, with an ultimate completion date of August 18, 2025. This contract represents a non-set-aside competitive award and is categorized as a child contract, indicating it derives from a larger vehicle. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its...
- The Defense Logistics Agency awarded a $1,566.63 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (two-pack units). This is a firm fixed-price contract with no set-aside designation, competitively awarded through an open process. The contract specifies a completion date of September 2, 2025, and AmerisourceBergen will perform the work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMXAHDelivery Order
The Defense Logistics Agency awarded a $1,874.14 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.15 mg auto-injectors (2-pack) on July 31, 2025, with an ultimate completion date of August 1, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania serves as the place of performance for this delivery order, which falls under the company's broader relationship with the DLA Medical Supply Chain. This delivery order is a child contract issued against AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates significant capability in fulfilling critical medical procurement needs across multiple therapeutic domains, positioning the company as a key pharmaceutical distributor for Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 7/31/25 |